Biophytis S.A.
NASDAQ: BPTS0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Capital Market
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Stanislas Veillet
- Employees
- 22
- Headquarters
- Paris, France
- IPO year
- 2021
- Market cap
- $2.6M
- Website
- https://www.biophytis.com
Loading BPTS…
Loading profile data…Frequently asked questions about BPTS
What does Biophytis S.A. (BPTS) do?
Biophytis S.A. operates as a clinical-stage biotechnology firm dedicated to advancing therapeutic solutions aimed at decelerating degenerative processes and enhancing functional outcomes for individuals grappling with age-related illnesses. These therapies function by targeting and stimulating critical biological resilience pathways, which are d...
Where does BPTS trade?
Biophytis S.A. (BPTS) trades on the NASDAQ Capital Market.
What sector is BPTS in?
Biophytis S.A. (BPTS) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Biophytis S.A.?
Stanislas Veillet is the chief executive officer of Biophytis S.A. (BPTS).
Where is Biophytis S.A. headquartered?
Biophytis S.A. is headquartered in France.
Does BPTS pay a dividend?
Biophytis S.A. (BPTS) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did BPTS go public?
Biophytis S.A. (BPTS) completed its initial public offering in 2021.
Is BPTS an ADR?
Yes — BPTS is an American Depositary Receipt; its underlying shares trade on a non-US exchange. Biophytis S.A. reporting and dividends follow the underlying issuer.